Author Response: Effect of ruboxistaurin on the visual acuity decline associated with long-standing diabetic macular edema

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 12, 2010, Pages 6890-6891

  Sheetz, Matthew J ^a   Davis, Matthew D ^b   Aiello, Lloyd P ^c   Milton, Roy C ^d   Danis, Ronald P ^b   Zhi, Xin ^a   Girach, Aniz ^a   Jimenez, Maria C ^a   Vignati, Louis ^a  

^a ELI LILLY AND COMPANY   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d EMMES CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RUBOXISTAURIN;

DIABETIC MACULAR EDEMA; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FOLLOW UP; HUMAN; LETTER; PRIORITY JOURNAL; VISUAL ACUITY;

EID: 79955978493     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-4285     Document Type: Letter

References (2)

1. Davis MD, Sheetz MJ, Aiello LP, et al. Effect of ruboxistaurin on the visual acuity decline associated with long-standing diabetic macular edema. Invest Ophthalmol Vis Sci. 2009;50:1-4.
2. The PKC-DRS2 Study Group. Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy. Ophthalmology. 2006;113: 2221-2230.